Key facts
- Almanac Health’s last known valuation is $64.0M (Mar 2026).
- It has raised $11.8M across 1 recorded rounds; the latest was Early Stage VC ($11.9M) in Mar 2026.
- Almanac Health has filed 1 Form D with the SEC, most recently Mar 2026 ($11.9M sold to 15 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Almanac Health
Funding rounds
1 roundsAbout Almanac Health
Developer of a medical knowledge platform intended for healthcare professionals. The company's platform gives medical answers, guidelines, calculates risk scores, and writes prior authorization letters, enabling medical professionals to get evidence-based answers at the moment of care.
- Sector
- Business Products and Services (B2B)
- HQ
- Dover, DE, United States
- Founded
- 2025
- Ownership
- Privately Held (backing)
Almanac Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Almanac Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Almanac Health in its N-PORT filings yet. We sweep new filings monthly.